265 related articles for article (PubMed ID: 10799590)
1. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
Marshall D; Sample C
J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
[TBL] [Abstract][Full Text] [Related]
5. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
6. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
Laux G; Adam B; Strobl LJ; Moreau-Gachelin F
EMBO J; 1994 Dec; 13(23):5624-32. PubMed ID: 7988559
[TBL] [Abstract][Full Text] [Related]
7. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
Zhao B; Marshall DR; Sample CE
J Virol; 1996 Jul; 70(7):4228-36. PubMed ID: 8676443
[TBL] [Abstract][Full Text] [Related]
8. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
Jiang H; Cho YG; Wang F
J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
[TBL] [Abstract][Full Text] [Related]
9. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Lin J; Johannsen E; Robertson E; Kieff E
J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
Harada S; Kieff E
J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
[TBL] [Abstract][Full Text] [Related]
14. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
West MJ; Webb HM; Sinclair AJ; Woolfson DN
J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
Sample C; Parker B
Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
[TBL] [Abstract][Full Text] [Related]
17. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
[TBL] [Abstract][Full Text] [Related]
18. A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.
Tzellos S; Correia PB; Karstegl CE; Cancian L; Cano-Flanagan J; McClellan MJ; West MJ; Farrell PJ
J Virol; 2014 Aug; 88(16):8743-53. PubMed ID: 24850736
[TBL] [Abstract][Full Text] [Related]
19. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
Bourillot PY; Waltzer L; Sergeant A; Manet E
J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
